Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.365 USD | -2.50% | +10.89% | +10.89% |
23/04 | Averoa Seeks EU Approval for Chronic Kidney Disease Drug | MT |
16/04 | Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited Enters into Second Amendment to the Supply Agreement | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.89% | 293M | |
+2.89% | 106B | |
+7.02% | 23.47B | |
-14.75% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.59% | 16.78B | |
+6.60% | 14.41B | |
+34.70% | 12.86B | |
+317.46% | 8.78B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- Sector Update: Health Care Stocks Advance Premarket Thursday